The integration supports treatment decisions across cancer care stages and helps reduce administrative tasks for clinicians.

Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Join us in Minneapolis to hear more from keynote speaker Lisa Earnhardt, at DeviceTalks Minnesota on May 4, 2026.

Whoop noted that alongside Abbott, the company's share a mutual interest in "empowering people to take control of their ...

Abbott Park, Ill.-based Abbott Laboratories and Saint Paul, Minn.-based St. Jude Medical — which Abbott is in the process of acquiring for $25 billion — plan to sell several medical devices to ...

Medical devices continue to be a strong growth driver for Abbott, as the company battles its ongoing sales slump in diagnostics, which accelerated in the third quarter. Third-quarter revenue for its ...

Abbott, a healthcare conglomerate with businesses and products spanning diagnostics, medical devices, nutrition and more, ...

Johnson & Johnson offers scale and stability, but Abbott’s cheaper valuation, higher yield, and stronger upside make it the ...

(NBC CHICAGO) — The Food and Drug Administration issued an alert about a "potentially high-risk issue" regarding malfunctioning Abbott glucose sensors that have been linked to more than 700 serious ...

Abbott (NYSE:ABT) announced today that it integrated its comprehensive Precision Oncology portfolio into Flatiron's OncoEMR ...